journal article·2022-12-31Open access

Indocyanine green-loaded exosomes for image-guided glioma nano-therapy

Bo Fan, Song Yang, Yuan-yu Wang, Chao Zhang, Ji-peng Yang, Li-qun Wang, Zhong-qiang Lv, Xue-fang Shi, Zhen-zeng Fan, Jian-kai Yang

Abstract

Glioblastoma multiforme (GBM) is the most aggressive and deadliest type of brain tumor with a > >th he most aggressive and deadliest type of brain tumor witnear-infrared fluorescent dye, but it is hard to directly target brain tumor. Therefore, our study aimed to develop a new carrier for ICG to accurately visualize cancer tissue during surgery. Exosomes were isolated from culture U-87 MG cells, then loaded with Indocyanine green (ICG) and conjugated with RGERPPR peptide (RGE) (R-exo-ICG). The parameters of R-exo-ICG were analyzed and injected into tumor-bearing nude mice to evaluate its anti-tumor effect. R-exo-ICGs were nano size, and completely released ICG within 24 h. RGE modification increased cell uptake of exosomes, and induced cell apoptosis through activating Caspase 3 signaling pathway after laser irradiation. Moreover, R-exo-ICG was largely accumulated in the brain tumor in vivo, and inhibited tumor growth in tumor-bearing mice. RGE-conjugated exosomes that loaded ICG could target brain tumor in mice and significantly inhibited tumor growth in mice, which suggested that R-exo-ICG might serve as a novel approach for GBM treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Nanoplatforms for cancer theranostics · Advanced Nanomaterials in Catalysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

The Second Hospital of Hebei Medical University, Shijiazhuang, China

Funding

S&T Program of Hebei · Beijing-Tianjin-Hebei Province Basic Research Cooperation Project · Provincial Clinical Medical Talents Project in 2021 · Hebei high level Talents Project · the Hebei Medical University-Hebei Provincial Science and Technology Department Innovation Fund

References (27)

Show source-provided references
1. 10.15252/emmm.20130262710.15252/emmm.201302627 ↗
2. 10.1126/sciadv.160050210.1126/sciadv.1600502 ↗
3. 10.1038/s41392-020-00261-010.1038/s41392-020-00261-0 ↗
4. Ingle AP, Gupta I, Duran N, et al. Nanotherapy: a next generation hallmark for combating cancer. Nanostructures for cancer therapy. Amsterdam: Elsevier; 2017. p. 811–830.10.1016/B978-0-323-46144-3.00029-5 ↗
5. 10.1016/j.addr.2012.07.00210.1016/j.addr.2012.07.002 ↗
6. 10.1194/jlr.R08434310.1194/jlr.R084343 ↗
7. 10.1039/C9AN00795D10.1039/C9AN00795D ↗
8. 10.1039/C9CC00962K10.1039/C9CC00962K ↗
9. 10.1038/s41598-020-58239-510.1038/s41598-020-58239-5 ↗
10. 10.1002/bio.302810.1002/bio.3028 ↗
11. 10.1002/pros.2384410.1002/pros.23844 ↗
12. 10.2967/jnumed.119.23315510.2967/jnumed.119.233155 ↗
13. 10.1148/radiol.202120413410.1148/radiol.2021204134 ↗
14. 10.7150/thno.3855410.7150/thno.38554 ↗
15. Ramírez Backhaus M · Arch Esp Urol · 2019 · 72 · 831
16. 10.1016/j.biomaterials.2018.06.02910.1016/j.biomaterials.2018.06.029 ↗
17. 10.1161/CIRCRESAHA.112.27052010.1161/CIRCRESAHA.112.270520 ↗
18. 10.1161/ATVBAHA.117.30985910.1161/ATVBAHA.117.309859 ↗
19. 10.1021/acs.bioconjchem.8b0066910.1021/acs.bioconjchem.8b00669 ↗
20. 10.1002/anie.20190564310.1002/anie.201905643 ↗
21. 10.2174/092986732566618083115025910.2174/0929867325666180831150259 ↗
22. 10.1038/nmat447610.1038/nmat4476 ↗
23. 10.1021/acsnano.8b0655610.1021/acsnano.8b06556 ↗
24. 10.1002/path.477110.1002/path.4771 ↗
25. 10.1002/adfm.20170307410.1002/adfm.201703074 ↗
26. 10.1038/s41598-019-44569-610.1038/s41598-019-44569-6 ↗
27. 10.1038/s41388-019-0782-x10.1038/s41388-019-0782-x ↗